Ralf Kuriyel, Senior VP, R&D at REPLIGEN CORP (RGEN), sold 4,480 shares at $58.53 ($262K) on 2019-03-05, disclosed to the SEC on 2019-03-05.
Open-market sale of $262k RGEN by Senior VP, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.53 | 2,240 | $131K | 50.0% |
| 2 | $58.53 | 2,240 | $131K | 50.0% |
| Total | $58.53 avg | 4,480 | $262K | 100% |
| Filing → |
| RGEN | SELL | 2024-03-12 | $1.4M | — | Filing → |
| RGEN | SELL | 2022-08-12 | $2.3M | — | Filing → |
| RGEN | SELL | 2021-09-02 | $2.3M | — | Filing → |